Wonhyo Seo Assistant Professor

Pharmaceutical Sciences/Division of Pharmacy/Industrial Pharmaceutical Science

서원효 프로필 사진

				
  • Pharmaceutical Science Building B #303
  • 02-3277-3366
  • Research Interests
    • alcoholic liver diseases, interaction between hepatic cells and non-parenchymal cells, Development of acute/chronic liver disease mouse model
Research Record
  • Aloe-derived nanovesicles attenuate inflammation and enhance tight junction proteins for acute colitis treatment Biomaterials Science, 2023, v.11 no.16, 5490-5501
    SCIE Scopus dColl.
  • Ethanol and its Nonoxidative Metabolites Promote Acute Liver Injury by Inducing ER Stress, Adipocyte Death, and Lipolysis Cellular and Molecular Gastroenterology and Hepatology, 2023, v.15 no.2, 281-306
    SCIE Scopus dColl.
  • Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases Biomolecules and Therapeutics, 2023, v.31 no.3, 253-263
    SCIE Scopus KCI dColl.
  • Experimental models of fatty liver diseases: Status and appraisal HEPATOLOGY COMMUNICATIONS, 2023, v.7 no.7, e00200
    SCIE Scopus dColl.
  • Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis Journal of Medicinal Chemistry, 2023, v.66 no.23, 16342-16363
    SCIE Scopus dColl.
  • Pomegranate-Derived Exosome-Like Nanovesicles Alleviate Binge Alcohol-Induced Leaky Gut and Liver Injury Journal of Medicinal Food, 2023, v.26 no.10, 739-748
    SCIE Scopus KCI dColl.
  • Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice Journal of Controlled Release, 2023, v.355, 184-198
    SCIE Scopus dColl.
  • Alcoholic liver disease: a new insight into the pathogenesis of liver disease Archives of Pharmacal Research, 2022, v.45 no.7, 447-459
    SCIE Scopus KCI dColl.
  • Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress ANTIOXIDANTS, 2021, v.10 no.9, 1386
    SCIE Scopus dColl.
  • MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, v.17 no.4, 1153-1167
    SCIE Scopus dColl.
  • Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis JOURNAL OF CLINICAL INVESTIGATION, 2021, v.131 no.3, e141513
    SCIE Scopus dColl.
  • Disulfiram Treatment Normalizes Body Weight in Obese Mice CELL METABOLISM, 2020, v.32 no.2, 203-
    SCIE Scopus dColl.
  • Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice JOURNAL OF HEPATOLOGY, 2020, v.72 no.4, 736-745
    SCIE Scopus dColl.
  • Mitochondrial Double-Stranded RNA in Exosome Promotes Interleukin-17 Production Through Toll-Like Receptor 3 in Alcohol-associated Liver Injury HEPATOLOGY, 2020, v.72 no.2, 609-625
    SCIE Scopus dColl.
  • Protective and Detrimental Roles of p38 alpha Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease HEPATOLOGY, 2020, v.72 no.3, 873-891
    SCIE Scopus dColl.
  • [학술지논문] Aloe-derived nanovesicles attenuate inflammation and enhance tight junction proteins for acute colitis treatment BIOMATERIALS SCIENCE, 2023, v.11 no.16 , 5490-5501
    SCIE
  • [학술지논문] Ethanol and its Nonoxidative Metabolites Promote Acute Liver Injury by Inducing ER Stress, Adipocyte Death, and Lipolysis CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, v.15 no.2 , 281-306
    SCIE
  • [학술지논문] Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases BIOMOLECULES & THERAPEUTICS, 2023, v.31 no.3 , 253-263
    SCIE
  • [학술지논문] Experimental models of fatty liver diseases: Status and appraisal HEPATOLOGY COMMUNICATIONS, 2023, v.7 no.7 , 1-8
    SCIE
  • [학술지논문] Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis JOURNAL OF MEDICINAL CHEMISTRY, 2023, v.66 no.23 , 16342-16363
    SCIE
  • [학술지논문] Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice JOURNAL OF CONTROLLED RELEASE, 2023, v.355 no.0 , 184-198
    SCIE
  • [학술지논문] Alcoholic liver disease: a new insight into the pathogenesis of liver disease ARCHIVES OF PHARMACAL RESEARCH, 2022, v.45 no.7 , 447-459
    SCIE
  • [학술지논문] Hepatic CYP2B10 is highly induced by binge ethanol and contributes to acute-on-chronic alcohol-induced liver injury ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, v.46 no.12 , 2163-2176
    SCI
Courses
  • 2024-1st

    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 01
      • 4Year ( 3Credit , 3Hour) Wed 3~3 (PHM-A100-1) , Fri 5~5 (PHM-A104)
      • Major Requisite
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 02
      • 4Year ( 3Credit , 3Hour) Wed 5~5 (POSCO552) , Fri 6~6 (PHM-A104)
      • Major Requisite
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 03
      • 4Year ( 3Credit , 3Hour) Wed 2~2 (PHM-A100-1) , Fri 3~3 (PHM-A100-1)
      • Major Requisite
    • Toxicology

      • Subject No 36204Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Tue 2~2 (PHM-A400)
    • Toxicology

      • Subject No 36204Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Tue 5~5 (POSCO)
    • Pharmaceutical Experiment Laboratory Ⅲ 강의 계획서 상세보기

      • Subject No 37126Class No 01
      • 4Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ 강의 계획서 상세보기

      • Subject No 37126Class No 02
      • 4Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ 강의 계획서 상세보기

      • Subject No 37126Class No 03
      • 4Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A303-1)
      • Major Requisite
    • Introduction to Pharmaceutical Research

      • Subject No 39045Class No 01
      • 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A100-1)
  • 2023-2nd

  • 2023-1st

  • 2022-2nd

    • Preventive Pharmaceutics II

      • Subject No 22513Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Fri 4~4 (ECC)
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Fri 3~3 (ECC)
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 03
      • 4Year ( 1.5Credit , 1.5Hour) Mon 2~2 (PHM-A104)
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 04
      • 4Year ( 1.5Credit , 1.5Hour) Mon 2~2 (PHM-A104)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 01
      • 4Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 02
      • 4Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 03
      • 4Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 04
      • 4Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A303-1)
      • Major Requisite
    • Advanced Pharmacy Practice and Research Ⅲ

      • Subject No 37156Class No 01
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Challenges in global health

      • Subject No 37802Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Wed 4~4 (PHM-A400)
    • Challenges in global health

      • Subject No 37802Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Fri 6~6 (PHM-A400)
    • Challenges in global health

      • Subject No 37802Class No 03
      • 4Year ( 1.5Credit , 1.5Hour) Fri 6~6 (PHM-A400)
    • Laboratory animal research for drug development

      • Subject No G18401Class No 01
      • Year ( 3Credit , 3Hour) Tue 2~3 (PHM-)
  • 2022-1st

    • First-Year Seminar

    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 01
      • 4Year ( 3Credit , 3Hour) Wed 2~2 (POSCO161) , Fri 3~3 (POSCO161)
      • Major Requisite
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 02
      • 4Year ( 3Credit , 3Hour) Wed 3~3 (POSCO161) , Fri 5~5 (POSCO161)
      • Major Requisite
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 03
      • 4Year ( 3Credit , 3Hour) Wed 5~5 (POSCO261) , Fri 6~6 (POSCO261)
      • Major Requisite
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 04
      • 4Year ( 3Credit , 3Hour) Wed 5~5 (POSCO261) , Fri 6~6 (POSCO261)
      • Major Requisite
    • Toxicology

      • Subject No 36204Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Mon 3~3 (PHM-A400)
    • Toxicology

      • Subject No 36204Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Fri 2~2 (PHM-A404)
    • Toxicology

      • Subject No 36204Class No 03
      • 4Year ( 1.5Credit , 1.5Hour) Fri 2~2 (PHM-A404)
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 01
      • 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 02
      • 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 03
      • 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A303-1)
      • Major Requisite
    • Honors research

      • Subject No 37803Class No 01
      • 4Year ( 1Credit , 1Hour)
  • 2021-2nd

    • Preventive Pharmaceutics II

      • Subject No 22513Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Wed 2~2
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Tue 2~2
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 03
      • 4Year ( 1.5Credit , 1.5Hour) Wed 3~3
      • Major Requisite
    • Preventive Pharmaceutics II

      • Subject No 22513Class No 04
      • 4Year ( 1.5Credit , 1.5Hour) Wed 3~3
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 01
      • 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 02
      • 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 03
      • 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 04
      • 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A303-1)
      • Major Requisite
    • Academic Speaking in Pharmaceutical Sciences

      • Subject No 37800Class No 01
      • 3Year ( 1.5Credit , 1.5Hour) Tue 1~1
    • Academic Speaking in Pharmaceutical Sciences

      • Subject No 37800Class No 02
      • 3Year ( 1.5Credit , 1.5Hour) Tue 1~1
    • Challenges in global health

      • Subject No 37802Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Wed 1~1
    • Challenges in global health

      • Subject No 37802Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Mon 3~3
    • AAPS biotechnology fundamentals of biotherapeutics development

      • Subject No 37815Class No 01
      • 6Year ( 1.5Credit , 1.5Hour) Sat 3~3
    • Seminar for Pharmaceutical Sciences II

      • Subject No G16888Class No 01
      • Year ( 3Credit , 3Hour) Thu 7~8 (PHM-A400)
  • 2021-1st

    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 01
      • 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 3~3
      • Major Requisite,Language Changed
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 02
      • 4Year ( 3Credit , 3Hour) Wed 3~3 , Fri 5~5
      • Major Requisite,Language Changed
    • Preventive Pharmaceutics Ⅰ

      • Subject No 22515Class No 03
      • 4Year ( 3Credit , 3Hour) Wed 3~3 , Fri 5~5
      • Major Requisite,Language Changed
    • Toxicology

      • Subject No 36204Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Wed 5~5
      • Language Changed
    • Toxicology

      • Subject No 36204Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Wed 5~5
      • Language Changed
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 01
      • 4Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 02
      • 4Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A303-1)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory Ⅲ

      • Subject No 37126Class No 03
      • 4Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A303-1)
      • Major Requisite
Academic Background

Korea Advanced Institute of Science & Technology 이학박사(의과학학제학)

University of Pretoria M.S.(수의학과)

Kyungpook Nat'l Univ. 수의학사(수의학과)

Work Experience

미국립보건원(NIH) 2016-06-15 ~ 2021-03-01

카이스트 2016-03-01 ~ 2016-06-14